Order results by:
| Issue | Title | |
| Vol 17, No 4 (2021) | Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention | Abstract similar documents |
| A. V. Panov | ||
| "... recommended that the default strategy after recent PCI is a double antithrombotic therapy consisting ..." | ||
| Vol 8, No 4 (2012) | THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY | Abstract similar documents |
| M. Yu. Gilyarov | ||
| "... Up to date antithrombotic medications applied in patients with atrial fibrillation are discussed ..." | ||
| Vol 9, No 2 (2013) | ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS | Abstract similar documents |
| O. V. Shatalova, O. N. Smuseva, A. S. Maslakov | ||
| "... Aim. To analyze adverse drug reactions (ADR) during antithrombotic therapy on the basis ..." | ||
| Vol 16, No 5 (2020) | Treatment of Patients with Acute Coronary Syndrome with ST Segment Elevation in Clinical Practice of the Republic of Karelia: the Results of 10-year Register | Abstract similar documents |
| I. S. Skopets, N. N. Vezikova, A. V. Malafeev, A. N. Malygin, V. A. Litvinova | ||
| "... of reperfusion interventions (83.5%) with a predominance of percutaneous coronary intervention (PCI; 76 ..." | ||
| Vol 8, No 4 (2012) | WARFARIN IN PATIENTS WITH CARDIOEMBOLIC STROKE | Abstract similar documents |
| E. N. Dankovtseva, S. L. Arkhipov, D. A. Zateyshchikov | ||
| "... with antithrombotic medications are shown in details. Possibility to apply thrombolysis during warfarin treatment ..." | ||
| Vol 13, No 6 (2017) | THIOL ISOMERASES – A POSSIBLE TARGET FOR THROMBOSIS CONTROL | Abstract similar documents |
| I. V. Gribkova, M. V. Davydovskaya | ||
| "... of antithrombotic agents with both antiplatelet and anticoagulant properties to prevent thrombosis in humans. ..." | ||
| Vol 16, No 5 (2020) | Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis) | Abstract similar documents |
| O. V. Reshetko, A. V. Sokolov, N. V. Furman, V. V. Agapov | ||
| "... ) in the Saratov Region for 5 years by analyzing the antithrombotic therapy of patients who were admitted ..." | ||
| Vol 7, No 5 (2011) | ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES | Abstract similar documents |
| Ya. P. Dovgalevskiy, L. E. Kuvshinova, I. V. Graifer, N. V. Furman, P. Ya. Dovgalevskiy | ||
| "... Recent data and perspectives of antithrombotic therapy in patients with atrial fibrillation (AF ..." | ||
| Vol 17, No 6 (2021) | Changes in Prescribing Antithrombotic Therapy in Patients with Atrial Fibrillation in the Multidisciplinary Hospital in Volgograd from 2012 to 2020 | Abstract similar documents |
| A. S. Gerasimenko, O. V. Shatalova, V. S. Gorbatenko, V. I. Petrov | ||
| "... Aim. To study the frequency of prescribing antithrombotic agents in patients with non-valvular ..." | ||
| Vol 18, No 6 (2022) | Perioperative Management of Patients Receiving Antithrombotic Therapy in Schemes and Algorithms | Abstract similar documents |
| O. N. Dzhioeva, E. A. Rogozhkina, O. M. Drapkina | ||
| "... Currently, antithrombotic therapy is the basis of the pathogenetic treatment of many ..." | ||
| Vol 18, No 2 (2022) | Antithrombotic Therapy and the Nearest Forecast of Pulmonary Embolism in Rutine Clinical Practice (Data of the Regional Vascular Center of the Ryazan Region) | Abstract similar documents |
| N. N. Nikulina, Yu. V. Terekhovskaya, S. S. Yakushin | ||
| "... Aim. To perform the analysis of antithrombotic therapy and immediate prognosis in patients ..." | ||
| Vol 10, No 6 (2014) | THE ASSESSMENT OF COMPLIANCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE PROFILE REGISTER | Abstract similar documents |
| S. Y. Martsevich, A. R. Navasardyan, N. P. Kutishenko, A. V. Zakharova, V. P. Voronina, N. A. Dmitrieva, L. Yu. Lrozdova, A. V. Zagrebelnyy, O. V. Lerman, Yu. V. Lukina, G. V. Martynova, A. A. Nikulina, G. S. Ryazanova, A. Yu. Suvorov, S. N. Tolpygina | ||
| "... Aim. To study in the PROFILE register the rate of new oral anticoagulants (NOAC) taking ..." | ||
| Vol 15, No 1 (2019) | Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation | Abstract similar documents |
| V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko | ||
| "... Aim. To study the frequency of prescribing antithrombotic agents in patients with non-valvular ..." | ||
| Vol 14, No 4 (2018) | Elderly Patient Management Problems: Antithrombotic Therapy Selection Features. Clinical Case | Abstract similar documents |
| D. U. Akasheva, E. S. Bulgakova, I. S. Yavelov, A. Yu. Gorshkov, O. M. Drapkina | ||
| "... The growing population of elderly people is the main «antithrombotic drugs consumer» because ..." | ||
| Vol 15, No 1 (2019) | Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City | Abstract similar documents |
| A. A. Tuchkov, N. G. Gogolashvili, R. A. Yaskevich | ||
| "... Aim. To evaluate the volume of antithrombotic therapy (ATT) at the prehospital stage in connection ..." | ||
| Vol 16, No 1 (2020) | Clinical Significance of Thrombin Blockade with Low Doses (2.5 mg) of Rivaroxaban in Ischemic Heart Disease Patients | Abstract similar documents |
| A. B. Sumarokov, L. I. Buryachkovskaya, Y. V. Docenko, M. S. Kurochkin, N. V. Lomakin | ||
| "... factors in plasma and vessel wall. Antiplatelet drugs do not always provide the necessary antithrombotic ..." | ||
| Vol 14, No 6 (2018) | Antithrombotic Therapy in Patients with Atrial Fibrillation after Myocardial Infarction: Clinical Guidelines and Actual Practice | Abstract PDF (Eng) similar documents |
| K. G. Pereverzeva, S. S. Yakushin, A. E. Pripadcheva, N. P. Agaltsova | ||
| "... Aim. To study the frequency of oral anticoagulants (ОАС) prescription for patients with atrial ..." | ||
| Vol 8, No 5 (2012) | RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE | Abstract similar documents |
| I. V. Grajfer, L. E. Kuvshinova, P. V. Dolotovskaya, O. V. Reshet'ko, N. V. Furman | ||
| "... Aim. Тo evaluate compliance of ongoing antithrombotic therapy (ATT) in various forms of atrial ..." | ||
| Vol 19, No 2 (2023) | Antithrombotic Therapy in Patients with Paroxysmal Atrial Fibrillation after Catheter Treatment | Abstract similar documents |
| O. R. Eshmatov, M. S. Khlynin, R. E. Batalov, E. A. Archakov, I. V. Kisteneva | ||
| "... Aim. To study the efficacy and safety of antithrombotic therapy in patients with paroxysmal atrial ..." | ||
| Vol 14, No 2 (2018) | New Possibilities of Antithrombotic Therapy of Patients with Peripheral and Widespread Atherosclerotic Lesion | Abstract similar documents |
| A. L. Komarov, Е. S. Novikova, E. V. Guskova, Е. B. Yarovaya, A. N. Samko, E. Р. Panchenko | ||
| "... efficiency of present antiplatelet and anticoagulant drugs is shown in the key of preventing PAD thrombotic ..." | ||
| Vol 4, No 3 (2008) | ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS | Abstract similar documents |
| V. A. Sulimov | ||
| "... Possibilities of modern antiplatelet and antithrombotic therapy at percutaneous coronary ..." | ||
| Vol 8, No 3 (2012) | RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| M. Yu. Gilyarov | ||
| "... The possibilities of antithrombotic therapy in atrial fibrillation are highlighted ..." | ||
| Vol 16, No 3 (2020) | The Short-Term Effect of Stent Size and Number on Left Ventricular Systolic Function Improvement After Elective Percutaneous Coronary Intervention | Abstract PDF (Eng) similar documents |
| Sh. Mostafa, O. Sanad, M. Shawky, M. Magdy, E. Elkeshk | ||
| "... after percutaneous coronary intervention (PCI) using drug eluting stent is not clear enough. Aim ..." | ||
| Vol 13, No 1 (2017) | EVALUATION OF TREATMENT OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION BEFORE REFERENCE EVENT AND BEFORE DISCHARGE FROM THE HOSPITAL: REGISTER DATA (KHABAROVSK CITY). PART 2 | Abstract similar documents |
| L. N. Malay, S. Yu. Martsevich, L. V. Solokhina, Y. M. Bukhonkina, K. E. Poshatayev, N. B. Garayeva, A. Ya. Letskin | ||
| "... (PCI), as well as hospital outcomes according to the AMI Register. Material and methods. 321 patients ..." | ||
| Vol 6, No 1 (2010) | ANTITHROMBOTIC THERAPY AT AN ATRIAL FIBRILLATION: OLD PROBLEMS AND NEW SOLUTIONS | Abstract similar documents |
| M. Yu. Gilyarov, V. A. Sulimov | ||
| "... Обсуждается проблема выбора антитромботической терапии при фибрилляции предсердий. Помимо давно ..." | ||
| Vol 6, No 4 (2010) | ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS | Abstract similar documents |
| A. Y. Rychkov, N. Y. Khor'kova, A. A. Bliznyakov | ||
| Vol 7, No 3 (2011) | PROSPECTS FOR THE TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| V. A. Sulimov, A. S. Lishuta | ||
| Vol 20, No 6 (2024) | Multivessel coronary artery stenting complicated by stent thrombosis in the setting of hereditary thrombophilia: a clinical case | Abstract similar documents |
| Z. M. Safiullina, E. M. Mezhonov, S. V. Viatchinina, Yu. A. Vyalkina, A. Kh. Sereshcheva | ||
| "... triple and subsequently dual antithrombotic therapy. Repeated thrombosis necessitated surgical ..." | ||
| Vol 17, No 2 (2021) | Analysis of Anticoagulant Therapy in the Elderly Patients, in Clinical Practice of Family Medicine Centers in the Kyrgyz Republic | Abstract similar documents |
| S. M. Mamatov, B. Kanat kyzy, A. O. Musakeev, N. K. Kinderbaeva, T. J. Tagaev | ||
| "... Aim. To study the current state of the anticoagulant's prescription in elderly and senile patients ..." | ||
| Vol 13, No 2 (2017) | APPROACHES TO ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| E. A. Ushkalova, S. K. Zyryanov, E. V. Dumchenko | ||
| "... of patients with AF is 75 years. Antithrombotic therapy of AF in the elderly is challenging for several ..." | ||
| Vol 7, No 1 (2011) | ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS | Abstract similar documents |
| M. Yu. Gilyarov, V. A. Sulimov | ||
| "... New data and perspectives of antithrombotic therapy are highlighted in patients with atrial ..." | ||
| Vol 10, No 2 (2014) | ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| V. I. Petrov, O. V. Shatalova, A. S. Maslakov | ||
| "... Aim. To assess prescribing structure, efficacy and safety of antithrombotic therapy in in-patients ..." | ||
| Vol 17, No 5 (2021) | Optimum Treatment Strategy in Chronic Coronary Syndromes: the New Trials vs the Current Guidelines | Abstract similar documents |
| L. L. Bershtein, E. V. Zbyshevskaya, V. E. Gumerova | ||
| "... antithrombotic therapy. The data of the COMPASS study (NCT01776424) are discussed, based on which the addition ..." | ||
| Vol 16, No 3 (2020) | Coronary Artery Disease with a High Risk of Complications: How to Identify Such Patients and Choose Management Tactics? | Abstract similar documents |
| S. G. Kanorskii | ||
| "... factors for the progression of atherosclerosis and antithrombotic therapy to prevent atherothrombosis ..." | ||
| Vol 10, No 6 (2014) | PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION | Abstract similar documents |
| N. V. Mikheeva, O. V. Reshetko, N. V. Furman | ||
| Vol 11, No 5 (2015) | Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism | Abstract similar documents |
| A. V. Rudakova | ||
| "... oral anticoagulants (NOACs). Material and methods. Cost-effectiveness analysis was performed using ..." | ||
| Vol 12, No 2 (2016) | ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION? | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova, A. V. Rodionov | ||
| "... of antithrombotic therapy in the early (hospital) and the delayed periods (up to 1 year after acute ischemic events ..." | ||
| Vol 14, No 4 (2018) | Antithrombotic Therapy after Bleeding in Elderly Polimorbid Patient: Our Time Challenge | Abstract similar documents |
| M. R. Atabegashvili, M. Yu. Gilyarov, E. V. Konstantinova, A. N. Kostina, A. P. Nesterov, T. D. Pakharkova, A. E. Udovichenko | ||
| "... in the choice of antithrombotic therapy. This clinical case illustrates the difficulties in elderly polymorbid ..." | ||
| Vol 11, No 1 (2015) | PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| A. V. Rudakova | ||
| "... ) the following types of antithrombotic therapy are used: anticoagulant therapy with vitamin K antagonists ..." | ||
| Vol 7, No 6 (2011) | CORONARY EMBOLISM WITH FRAGMENTED THROMBUS FROM THE LEFT VENTRICLE IN PATIENT WITH POSTINFARCTION ANEURYSM | Abstract similar documents |
| Yu. F. Salakhova, S. V. Gar'kina, T. V. Kislukhin, D. V. Duplyakov, V. S. Ivanov, E. R. Perunova, E. I. Bazhenova, S. E. Burnazyan, S. M. Khokhlunov | ||
| "... and thrombus in the LV aneurysm is considered in details. Successful percutaneous coronary intervention (PCI ..." | ||
| Vol 11, No 2 (2015) | ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY | Abstract PDF (Eng) similar documents |
| V. A. Sulimov, D. A. Napalkov, A. A. Sokolova, A. V. Jilenko, O. S. Anikina | ||
| "... Aim. To study the structure and incidence of the in-hospital anticoagulants prescription ..." | ||
| Vol 9, No 6 (2013) | THROMBOLYSIS OR PRIMARY PCI FOR MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION? THE STREAM TRIAL (STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION) | Abstract similar documents |
| V. A. Sulimov | ||
| "... , coupled with timely coronary angiography, and primary percutaneous coronary intervention (PCI ..." | ||
| Vol 7, No 2 (2011) | PECULIAR PROPERTIES OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION. IS IT POSSIBLE TO DO THE TREATMENT SAFE? | Abstract similar documents |
| I. V. Zotova, D. A. Zateyshchikov | ||
| "... Arterial hypertension (HT) is a reason for raising a question about need for antithrombotic ..." | ||
| Vol 2, No 3 (2006) | ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? | Abstract similar documents |
| I. A. Latfullin, A. A. Podolskaya | ||
| "... of action and clinical efficiency of antithrombotic and antiplatelet medicines such as acetylsalicylic acid ..." | ||
| Vol 18, No 3 (2022) | Coagulation Disorders in Infective Endocarditis: Role of Pathogens, Biomarkers, Antithrombotic Therapy (Systematic Review) | Abstract PDF (Eng) similar documents |
| A. S. Pisaryuk, V. A. Zamarashkina, N. B. Safarova, N. M. Povalyaev, E. O. Kotova, U. I. Babukhina, E. M. Koltsova, Zh. D. Kobalava | ||
| "... The issue of antithrombotic therapy in patients with infective endocarditis has been studied ..." | ||
| Vol 17, No 2 (2021) | Features of Risk Stratification, Diagnosis and Secondary Prevention in Patients with Multifocal Arterial Disease. Part 2: Treatment Options | Abstract similar documents |
| V. G. Grachev, S. S. Vedenskaya, O. G. Smolenskaya | ||
| "... in patients with multifocal arterial lesions using antihypertensive, antithrombotic and lipid-lowering therapy ..." | ||
| Vol 17, No 1 (2021) | Features of Risk Stratification, Diagnosis and Secondary Prevention in Patients with Multifocal Arterial Disease. Part 1: Risk Stratification and Diagnosis | Abstract similar documents |
| V. G. Grachev, S. S. Vedenskaya, O. G. Smolenskaya | ||
| Vol 15, No 3 (2019) | Treatment of Patients with Stable Manifestations of Atherosclerosis: New Opportunities | Abstract similar documents |
| article Editorial | ||
| "... to antithrombotic therapy of stable patients with atherosclerotic diseases and its pathogenetic basis (inhibition ..." | ||
| Vol 16, No 6 (2020) | Actual Issues of Ischemic and Hemorrhagic Events Risk Management During Antithrombotic Therapy in Patients with Acute Coronary Syndrome | Abstract similar documents |
| R. M. Velieva, T. B. Pecherina, A. S. Vorobiev, V. V. Kashtalap, D. Yu. Sedykh | ||
| "... Today, optimal duration of double antiplatelet (DAPT) and triple antithrombotic therapy (TATT ..." | ||
| Vol 12, No 4 (2016) | Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true | Abstract similar documents |
| Yu. A. Bunin, S. V. Miklishanskaya | ||
| "... of them oral anticoagulants were used mainly from the group of vitamin K antagonists, most often warfarin ..." | ||
| Vol 10, No 3 (2014) | COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION | Abstract similar documents |
| A. V. Rudakova, V. A. Parfenov | ||
| "... fibrillation (NVAF) the following types of antithrombotic therapy are used: anticoagulant therapy with vitamin ..." | ||
| Vol 14, No 3 (2018) | APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova | ||
| "... The choice of anticoagulant therapy in patients with atrial fibrillation (AF) and concomitant ..." | ||
| Vol 18, No 1 (2022) | Modern Anticoagulant Therapy for Atrial Fibrillation: Patient Adherence in Clinical Practice | Abstract similar documents |
| Yu. P. Skirdenko, N. A. Nikolaev, K. G. Pereverzeva, A. Yu. Timakova, A. S. Galus, S. S. Yakushin | ||
| "... Aim. To assess the adherence of doctors and patients to anticoagulant therapy for atrial ..." | ||
| Vol 11, No 4 (2015) | EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME | Abstract similar documents |
| A. V. Rudakova, N. V. Lomakin | ||
| "... and modification of antithrombotic therapy in accordance with the received data can be considered as a cost ..." | ||
| Vol 16, No 2 (2020) | The Effect of Pharmacological Preconditioning with Nicorandil before Elective Coronary Stenting on the Long-Term Prognosis of Patients with Stable Coronary Artery Disease | Abstract similar documents |
| G. N. Soboleva, R. V. Gostishchev, A. N. Rogoza, T. I. Kotkina, A. N. Samko, Yu. A. Karpov | ||
| "... (PCI) to prevent myocardial injury and 4a type acute myocardial infarction (MI, primary endpoint ..." | ||
| Vol 15, No 5 (2019) | Prediction of the Possibility of Hemorrhagic Syndrome during Combined Antiplatelet Therapy According to the Krasnodar Region Registry | Abstract similar documents |
| Z. G. Tatarintseva, E. D. Kosmacheva, S. V. Kruchinova, V. A. Akinshina, A. A. Khalafyan | ||
| "... for the prevention of recurrent cardiovascular events and anticoagulant therapy for the prevention of thromboembolic ..." | ||
| Vol 13, No 4 (2017) | HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE? | Abstract similar documents |
| I. S. Yavelov, M. V. Zhatkina, O. M. Drapkina, A. Yu. Gorshkov, N. O. Myasnikova | ||
| "... statins in high doses before percutaneous coronary interventions (PCI) are presented in the review ..." | ||
| Vol 13, No 1 (2017) | CHANGE OF ARRHYTHMIC EVENTS IN ACUTE MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION AFTER PHARMACOINVASIVE REVASCULARIZATION | Abstract similar documents |
| V. E. Oleynikov, E. A. Shigotarova, A. V. Kulyutsin, E. V. Dushina, J. A. Guskova | ||
| "... intervention (PCI), were included into the study. Telemetry ECG was performed before and after PCI ..." | ||
| Vol 7, No 2 (2011) | COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE | Abstract similar documents |
| V. V. Omel'yanovskiy, E. V. Derkach, P. M. Khaylov, S. N. Tereshchenko | ||
| "... on reperfusion strategy (no reperfusion, percutaneous coronary intervention (PCI), prehospital thrombolysis ..." | ||
| Vol 17, No 1 (2021) | Myocardial Infarction Complicated by Ischemic Stroke: Risk Factors, Prognosis, Unresolved Problems and Possible Methods of Prevention | Abstract similar documents |
| M. V. Zykov, V. V. Butsev, R. R. Suleymanov | ||
| "... , followed by the appointment of anticoagulant therapy. Timely reperfusion treatment, the use of statins ..." | ||
| Vol 14, No 6 (2018) | P2Y12 Receptor Inhibitors in the Treatment of Patients with Acute Coronary Syndrome and Percutaneous Coronary Intervention: Possibilities of Prasugrel | Abstract PDF (Eng) similar documents |
| N. M. Vorobyeva | ||
| "... coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) are discussed in the article ..." | ||
| Vol 18, No 6 (2022) | Acute Coronary Syndrome after Percutaneous Coronary Intervention: State of the Problem and Clinical Practice Data | Abstract similar documents |
| I. S. Egorova, N. N. Vezikova | ||
| "... intervention (PCI), as well as the clinical features of the disease and lipid spectrum parameters. Material ..." | ||
| Vol 17, No 3 (2021) | The Effect of Clinical Characteristics and Stent Parameters on Left Ventricular Mechanical Dyssynchrony | Abstract PDF (Eng) similar documents |
| S. Mostafa, O. Sanad, M. Shawky, M. Magdy, E. Elkeshk | ||
| "... dyssynchrony after elective percutaneous coronary intervention (PCI) to left anterior descending (LAD) artery ..." | ||
| Vol 21, No 1 (2025) | The no-reflow phenomenon: current treatment and prevention strategies | Abstract similar documents |
| S. V. Dil, E. V. Vyshlov, M. A. Kercheva, L. N. Maslov, V. V. Ryabov | ||
| "... coronary intervention (PCI). This condition, characterized by inadequate microcirculation following ..." | ||
| Vol 14, No 2 (2018) | DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT | Abstract similar documents |
| N. В. Perepech, A. V. Tregubov | ||
| "... , if the patient with atrial fibrillation and a high risk of thromboembolism refused to take oral anticoagulants ..." | ||
| Vol 14, No 5 (2018) | Drug Therapy Structure and Clinical Characteristics of Patients with Atrial Fibrillation According to Data of REKUR-AF Study | Abstract similar documents |
| I. L. Polshakova, S. V. Povetkin | ||
| "... enzyme inhibitors, β-blockers, statins and diuretics. Anticoagulants were only used in 18 ..." | ||
| Vol 17, No 2 (2021) | Comorbidities and Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome | Abstract PDF (Eng) similar documents |
| M. Yu. Gilyarov, E. V. Konstantinova, M. R. Atabegashvili, T. D. Solntseva, D. A. Anichkov, А. N. Kostina, R. V. Polybin, A. E. Udovichenko, A. V. Svet | ||
| "... . Percutaneous coronary intervention (PCI) was performed in 42% of patients. In patients with STEMI and NSTEMI ..." | ||
| Vol 8, No 1 (2012) | RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION | Abstract similar documents |
| V. A. Sulimov, E. V. Moroz | ||
| "... in percutaneous coronary intervention (PCI), to identify clinical risk factors of resistance development, to study ..." | ||
| Vol 18, No 6 (2022) | What is changing in the treatment of acute coronary syndrome in the Russian Federation? | Abstract similar documents |
| S. A. Boytsov, B. G. Alekyan, R. M. Shakhnovich, V. I. Ganyukov | ||
| "... coronary intervention (PCI) (by 9.6%) and in the general STEMI group (by 12.3%); significantly increased ..." | ||
| Vol 5, No 3 (2009) | ANTICOAGULANTS IN ACUTE CORONARY SYNDROME | Abstract similar documents |
| I. A. Latfullin, A. A. Podolskaya | ||
| Vol 14, No 4 (2018) | Hepatotoxicity of New Oral Anticoagulants | Abstract similar documents |
| A. R. Kasimova, A. V. Philippova (Guryanova), A. S. Kolbin | ||
| "... of various manifestations of liver damage in the use of the new oral anticoagulants (NOAC) for the registered ..." | ||
| Vol 12, No 5 (2016) | Clinical and Laboratory Predictors of Major Adverse Cardiac Events in Patients with Ischemic Heart Disease Following Elective Percutaneous Coronary Intervention | Abstract similar documents |
| E. Z. Golukhova, M. V. Grigoryan, M. N. Ryabinina, N. I. Bulaeva | ||
| "... pharmacological strategies, complications and adverse events following percutaneous coronary interventions (PCI ..." | ||
| Vol 9, No 3 (2013) | IMPACT OF LOCUS 9P21.3 SINGLE NUCLEOTIDE POLYMORPHISMS ON CORONARY ATHEROSCLEROSIS SEVERITY AND LONG-TERM OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENT WITH MYOCARDIAL INFARCTION | Abstract similar documents |
| P. A. Shesternya, G. V. Matyushin, S. Yu. Nikulina, A. S. Sergeeva | ||
| "... ) and coronary atherosclerosis severity and long-term outcomes after percutaneous coronary intervention (PCI ..." | ||
| Vol 10, No 6 (2014) | СONCOMITANT ADMINISTRATION OF CLOPIDOGREL AND PROTON PUMP INHIBITORS: ARE THERE ANY OPEN QUESTIONS LEFT TODAY? | Abstract similar documents |
| S. Yu. Martsevich, A. Yu. Suvorov | ||
| "... antithrombotic therapy increases the risk of upper gastrointestinal tract lesions. Concomitant administration ..." | ||
| Vol 10, No 4 (2014) | NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova | ||
| "... Comparative analysis of oral anticoagulants (vitamin K antagonists and new drugs, including ..." | ||
| Vol 13, No 6 (2017) | HEART RATE VARIABILITY, VENTRICULAR LATE POTENTIALS AND HEART RATE TURBULENCE AS INDICATORS OF CORONARY REPERFUSION IN ST SEGMENT ELEVATION MYOCARDIAL INFARCTION | Abstract similar documents |
| E. A. Shigotarova, E. V. Dushina, V. A. Galimskaya, V. E. Oleynikov | ||
| "... criteria, followed by (3-24 hour later) coronary angiography with percutaneous coronary intervention (PCI ..." | ||
| Vol 18, No 1 (2022) | Polymorbidity and Polypragmasia in High and Very High Cardiovascular Risk Patients | Abstract similar documents |
| N. V. Izmozherova, A. A. Popov, A. A. Kuryndina, E. I. Gavrilova, M. A. Shambatov, V. M. Bakhtin | ||
| "... .9%) were on oral anticoagulants for atrial fibrillation. Conclusion. In the structure of the studied ..." | ||
| Vol 8, No 3 (2012) | CARDIOPROTECTIVE EFFECT OF PHYSICAL REHABILITATION IN PATIENTS WITH ISCHEMIC-ORIGIN DIASTOLIC DYSFUNCTION AFTER PERCUTANEOUS CORONARY INTERVENTION | Abstract similar documents |
| N. P. Lyamina, A. N. Nosenko, I. B. Razborova, O. V. Orlikova, E. V. Kotel'nikova, E. S. Karpova | ||
| "... ) with left ventricle diastolic dysfunction (DD) who underwent percutaneous coronary intervention (PCI ..." | ||
| Vol 14, No 2 (2018) | WHAT ARE THE OPPORTUNITIES OF PRASUGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME | Abstract similar documents |
| M. Yu. Gilyarov, Е. V. Konstantinova | ||
| "... be considered in patients with ACS with percutaneous coronary intervention (PCI). Prasugrel therapy ..." | ||
| Vol 12, No 1 (2016) | Characteristic features, treatment and hospital outcomes in patients with acute myocardial infarction: Khabarovsk Register data. Part I | Abstract similar documents |
| L. N. Malay, L. V. Solokhina, Y. M. Bukhonkina, K. E. Poshatayev, H. B. Garayev, A. Ya. Letskin | ||
| "... ) admitted to the hospital with a possibility of primary percutaneous coronary intervention (PCI), according ..." | ||
| Vol 16, No 2 (2020) | Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation | Abstract similar documents |
| Yu. P. Skirdenko, N. A. Nikolaev | ||
| "... Aim. To evaluate the effectiveness of the anticoagulant choice algorithm in the prevention ..." | ||
| Vol 17, No 5 (2021) | Gastrointestinal Bleeding: a Cardiologist's Point of View | Abstract similar documents |
| O. V. Averkov, L. N. Mishchenko | ||
| "... Oral anticoagulant therapy is widely used in different patients for the prevention and treatment ..." | ||
| Vol 19, No 5 (2023) | Inhospital outcomes of myocardial infarction in patients receiving direct oral anticoagulants | Abstract similar documents |
| M. G. Chashchin, A. Yu. Gorshkov, O. M. Drapkina | ||
| "... ) in patients receiving continuous direct oral anticoagulant (DOAC) therapy. Material and methods. Data from ..." | ||
| Vol 14, No 1 (2018) | UTILIZING ENOXAPARIN IN THE MANAGEMENT OF ACUTE CORONARY SYNDROME | Abstract similar documents |
| O. V. Krikunova, R. I. Stryuk | ||
| "... Anticoagulant therapy is widely used in all forms of acute coronary syndrome (ACS) to inhibit ..." | ||
| Vol 10, No 4 (2014) | MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
| E. A. Belikov, K. V. Davtyan, O. N. Tkacheva | ||
| "... anticoagulants. ..." | ||
| Vol 14, No 6 (2018) | Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding | Abstract PDF (Eng) similar documents |
| A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin | ||
| "... anticoagulants (DOACs) inhibitors, as antidotes for DOAC when stopping life-threatening bleeding. DOAC therapy ..." | ||
| Vol 7, No 5 (2011) | HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION | Abstract similar documents |
| O. O. Shakhmatova, A. L. Komarov, A. N. Samko, T. I. Kotkina, D. V. Rebrikov, A. D. Deev, E. P. Panchenko | ||
| "... to daily maintenance) on long-term prognosis after elective percutaneous coronary intervention (PCI ..." | ||
| Vol 14, No 4 (2018) | Hospital Stage of Myocardial Infarction Treatment in 13 Regions of Russian Federation by Results of the International Research | Abstract PDF (Eng) similar documents |
| A. V. Kontsevaya, K. Bates, E. A. Goryachkin, N. Bobrova, L. I. Syromiatnikova, Yu. V. Popova, D. Yu. Platonov, I. V. Osipova, A. M. Nedbaikin, T. N. Malorodova, O. A. Mirolyubova, D. V. Kryuchkov, L. A. Khaisheva, A. S. Galyavich, M. V. Franz, A. Yu. Efanov, D. V. Duplyakov, O. M. Drapkina, D. Leon, M. McKee | ||
| "... PCI, and 2.2% CABG. Turning to cardiovascular risk factors, 46.2% of patients smoked prior ..." | ||
| Vol 20, No 4 (2024) | Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data | Abstract similar documents |
| A. I. Listratov, I. I. Ivanov, N. K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, D. A. Napalkov, A. A. Sokolova | ||
| "... Aim. To assess the compliance of nephroprotective and anticoagulant therapy in patients ..." | ||
| Vol 19, No 1 (2023) | Acute Coronary Syndrome during the Pandemic New Coronavirus Infection | Abstract similar documents |
| O. M. Drapkina, A. Ya. Kravchenko, A. V. Budnevskiy, A. V. Kontsevaya, E. S. Ovsyannikov, E. S. Drobysheva | ||
| "... (PCI), during a pandemic is experiencing great difficulties due to the formation of time delays ..." | ||
| Vol 18, No 4 (2022) | Impact of the COVID-19 Pandemic on Myocardial Revascularization in Patients with Acute Coronary Syndrome in the Russian Federation | Abstract PDF (Eng) similar documents |
| B. G. Alekyan, S. A. Boytsov, V. I. Ganyukov, E. M. Manoshkina | ||
| "... .3%); significantly increased mortality both in the general group (by 48%) and during PCI in patients with NSTE-ACS ..." | ||
| Vol 17, No 4 (2021) | Changes in anticoagulant prescription in a general hospital in 2008-2018 | Abstract similar documents |
| E. B. Kleymenova, V. A. Otdelenov, M. D. Nigmatkulova, S. A. Payushchik, A. A. Chernov, O. D. Konova, L. P. Yashina, A. M. Cherkashov, D. A. Sychev | ||
| "... Aim. To study the structure of anticoagulant prescription in a general hospital to identify trends ..." | ||
| Vol 13, No 3 (2017) | PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION | Abstract similar documents |
| A. V. Kryukov, D. A. Sychev, O. V. Tereshchenko | ||
| "... parameters of new oral anticoagulants. The review presents data from studies investigating the effect of gene ..." | ||
| Vol 9, No 4 (2013) | COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS | Abstract similar documents |
| V. A. Sulimov, D. A. Napalkov, A. A. Sokolova | ||
| "... Indirect comparisons of new oral anticoagulants are performed with focus on their safety. Apixaban ..." | ||
| Vol 16, No 3 (2020) | Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue | Abstract similar documents |
| O. D. Ostroumova, I. V. Goloborodova | ||
| "... and quality of life of the patient. Anticoagulants, widely used in the treatment of thromboembolic ..." | ||
| Vol 16, No 5 (2020) | Doctors’ Adherence to the Guidelines on the Oral Anticoagulants Usage | Abstract similar documents |
| N. B. Perepech, I. E. Mikhailova, A. V. Tregubov | ||
| "... Aim. To study doctors’ knowledge of the clinical guidelines on the use of oral anticoagulants ..." | ||
| Vol 14, No 4 (2018) | Atrial Fibrillation and Ventricular Arrhythmias in ST Segment Elevation Myocardial Infarction: Possibilities of Pharmacotherapy and Non-Pharmacological Treatment | Abstract similar documents |
| Yu. A. Bunin, S. A. Miklisanskaya, V. V. Chigineva, E. A. Zolozova | ||
| "... and argumentative issues of triple antithrombotic therapy in patients with AF with STEMI, the possibilities ..." | ||
| Vol 18, No 1 (2022) | Cerebrovascular Accident in a Patient with Polycythemia: a Case Report | Abstract similar documents |
| O. M. Drapkina, I. I. Almazova, A. V. Smirnova, S. A. Berns, R. N. Shepel | ||
| "... diagnosis and individual, pathogenetically grounded selection of means of long-term antithrombotic therapy ..." | ||
| Vol 20, No 3 (2024) | Use of glycoprotein IIb/IIIa inhibitors in myocardial infarction in the Russian Federation, according to the Russian Registry of Acute Myocardial Infarction REGION-IM | Abstract similar documents |
| N. S. Kostritca, R. M. Rabinovich, R. M. Shakhnovich, I. S. Yavelov, R. G. Gulyan, Yu. K. Rytova, S. N. Tereschenko, A. D. Erlikh, D. V. Pevzner | ||
| "... (PCI), while among patients with non-ST elevation myocardial infarction, the frequency of IIb/IIIa ..." | ||
| Vol 17, No 3 (2021) | Treatment and Secondary Prevention of Venous Thromboembolism in Real Clinical Practice Based on Health Care Professional Survey | Abstract similar documents |
| K. V. Lobastov, A. R. Navasardyan, I. V. Schastlivtsev | ||
| "... Aim. To assess the duration of the anticoagulant treatment of venous thromboembolism (VTE ..." | ||
| 1 - 100 of 256 Items | 1 2 3 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
.jpg)
